Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scienture HoldingsSCNX +0.43%43 EV-to-OCF is -1.38 as of Aug. 15, 2026. GuruFocus rates SCNX with a GF Score™ of 43/100 and a GF Value™ of $0.52 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Scienture Holdings ranks better than 73.61% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Scienture Holdings's Enterprise Value is $21.35 Mil.
Scienture Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-15.50 Mil. Therefore, Scienture Holdings's EV-to-OCF for today is -1.38.
The historical rank and industry rank for Scienture Holdings's EV-to-OCF or its related term are showing as below:
SCNX'
s EV-to-OCF Range Over the Past 10 Years
Min: -1529.52 Med: -1.77 Max: 1141.61
Current: -1.38
During the past 13 years, the highest EV-to-OCF of Scienture Holdings was 1141.61. The lowest was -1529.52. And the median was -1.77.
SCNX's EV-to-OCF is ranked better than 73.61% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.91
vs SCNX: -1.38
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Scienture Holdings's PE Ratio (TTM) for today is calculated as:
Scienture Holdings's share price for today is $0.459.
Scienture Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.100.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Scienture Holdings EV-to-OCF Related Terms
Scienture Holdings EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Scienture Holdings's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Scienture Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scienture Holdings EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Scienture Holdings's EV-to-OCF falls into.
Scienture Holdings's current Enterprise Value is $21.35 Mil.
Scienture Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.50 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scienture Holdings (SCNX) has a EV-to-OCF of -1.38 as of Aug. 15, 2026. According to the industry distribution chart, Scienture Holdings ranks #180 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 26.4%.
Is Scienture Holdings' EV-to-OCF too high?
Scienture Holdings' current EV-to-OCF is -1.38. Based on the distribution chart, Scienture Holdings ranks #180 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Scienture Holdings has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Scienture Holdings' EV-to-OCF compare to HEWA and BLMH?
According to the Healthcare Providers & Services industry distribution chart, Scienture Holdings ranks #180 out of 682 companies for EV-to-OCF. This puts Scienture Holdings in the upper half of its industry. The industry median EV-to-OCF is 8.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.91, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scienture Holdings's current EV-to-OCF is -1.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scienture Holdings stock overvalued right now?
Based on GuruFocus' analysis, Scienture Holdings (SCNX) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.52, compared to a current price of $0.46 — trading 11.7% below its estimated fair value. The current EV-to-OCF is -1.38. Scienture Holdings' overall GF Score™ is 43/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Scienture Holdings (SCNX), the current EV-to-OCF is -1.38 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scienture Holdings (SCNX) Overvalued in 2026?
Based on GuruFocus' analysis, Scienture Holdings stock appears to be undervalued.
The current stock price of $0.46 is trading 11.7% below its estimated GF Value™ of $0.52.
GuruFocus considers Scienture Holdings to be Modestly Undervalued.
Key valuation signals for SCNX:
EV-to-OCF: -1.38
GF Value™: $0.52 vs. price of $0.46 (11.7% below fair value)
No single metric tells the full story. See the SCNX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
43GF Score
Get the complete analysis for SCNX
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SCNX has been successfully added to your 
